DPx Launches as Global Provider of Pharmaceutical Services, Fine Chemicals and Proprietary TechnologiesMarch 11, 2014 3:16 pm | News | Comments
Formerly known by its provisional name “NewCo,” DPx is the corporate parent of a group of business units that is comprised of three distinct brands focused on pharmaceutical services, fine chemicals and products and proprietary technologies.
With the merger, the company extends its global footprint to include 20 operational offices in...
U.S. Sen. Joe Manchin is calling on the government's top health official to overturn the...
Uninsured Americans face an important deadline at the end of this month, and many don't realize...
Personalized Testing - BioReliance Builds a Biologics Clearance Service Facility That’s a Home Away from HomeMarch 11, 2014 4:09 pm | by Mike Auerbach, Editor in Chief @PharmProEditor | Articles | Comments
BioReliance, a company that provides testing and manufacturing services to pharmaceutical/biopharma companies, realized that the absence of full featured and customizable biological clearance testing facilities was an opportunity. The company’s recently opened facility in Rockville, MD offers their clients private and secure work lounges along with fully modular lab spaces that can be designed, equipped and ready-to-go upon their arrival.
A first-time mother who says she failed a drug test while in labor because she ate poppy seeds is suing a Pittsburgh hospital and says officials defamed her and violated her doctor-patient confidentiality by sharing the results with a child welfare agency.
An innovative hepatitis C drug that was only recently hailed as a breakthrough treatment is facing skepticism from some health care providers, as they consider whether it is worth the $1,000-a-pill price.
Human Longevity, Inc. plans to analyze DNA and use stem cell therapy to help people live a longer and healthier life. The company's co-founder and chief executive officer J. Craig Venter discusses how looking at an individual's genome could provide information about how long a person will live, as well as quality of life.
This session will provide an update on the PDA Task Force that is discussing strategies and risk management of Aging Facilities, and discuss some specific examples of unique challenges that manufacturers must deal with these facilities to maintain Good Manufacturing Practices.
With 25 years in operation, Praxis is an FDA cGMP certified contract packaging company specializing in secondary packaging for the consumer product, cosmetic, food & beverage, OTC and Rx pharmaceutical markets as well as bottling of oral solid dosage products.
President Barack Obama is hamming it up online to promote his health care plan. Obama joked Tuesday with comedian Zach , including poking fun at the poorly reviewed "Hangover Part III" during an interview on the website Funny or Die.
Romark Laboratories will complete the advanced development of Nitazoxanide (NT-300) as a treatment for acute uncomplicated influenza in a Phase III clinical study using the integrated eClinical products and services from DSG.
Peter Hanson, IPS' Director of Process Architecture, Asia and EMEA talks about changes in biopharmaceutical design for facilities in these emerging markets including shifts in investments and the types of investments.
The Obama administration says it's pulling the plug on proposed changes to the Medicare prescription program that ran into strong opposition on Capitol Hill.
Big pharmaceutical companies are deploying drug hunters to seek out and help acquire the promising early medicines that are key to revitalizing drug makers’ lineups and combating diseases.
In a new agreement, PBI will provide access to its extensive menu of validated biomarker assays to support WuXi's integrated clinical trial testing services. This includes bioanalysis and central laboratory services for pharmaceutical and biotech companies performing clinical drug development in China.
Almac has announced the expansion of its clinical services and technologies capabilities to include on-the-ground leadership as well as technical, project and operational resources in Asia. The company has established regional hubs in Singapore and Japan to better enable the industry’s growing need to conduct clinical trials in Asia and/or manage global trials from the region.
A new center at the University of Kansas Medical Center that focuses on stem cell research is conducting clinical trials only eight months after it opened.
It's not just grandma with a new hip and your uncle with a new knee. More than 2 of every 100 Americans now have an artificial joint, doctors are reporting. Among those over 50, it's even more common: Five percent have replaced a knee and more than 2 percent, a hip.